Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary

Summary

This phase II trial studies how well bevacizumab works in treating patients with sex cord-stromal tumors of the ovary that have come back. Monoclonal antibodies, such as bevacizumab, may block tumor growth in different ways by targeting certain cells. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor.

Timeline

Start

2008-09-22

Primary completion

2013-01-31

Completion

2013-01-31

Drugs

Indications